Bicarbonate

Bicarbonate

SCHEMBL372448

O.O=C([O-])[O-].O=C([O-])[O-].O=C([O-])[O-].[Ce+3].[Ce+3]

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CA4 P22748 5/20 0.46
CA1 P00915 3/20 0.46
FAHD1 Q6P587 1/20 0.46
LMNA P02545 2/20 0.36
MEN1 O00255 1/20 0.36
LDHA P00338 1/20 0.36
BLM P54132 1/20 0.36
KMT2A Q03164 1/20 0.36
CASP1 P29466 1/20 0.33
CA2 P00918 1/20 0.30
CA9 Q16790 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL3337412 1.00 CA4 (0.46) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL2791985 1.00 CA4 (0.46) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL28932444 1.00 CA4 (0.46) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL6691301 1.00 CA4 (0.46) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL8917975 1.00 CA4 (0.46) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL919437 1.00 CA4 (0.46) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL3686169 0.94
Bicarbonate SCHEMBL3683460 0.94 CA4 (0.42) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL28552920 0.94 CA4 (0.42) CA4CA1FAHD1LMNAMEN1
Bicarbonate SCHEMBL14563499 0.94 CA4 (0.42) CA4CA1FAHD1LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 552 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122076451-A Modified Ni/CeO2Preparation method and application of catalyst 2026-05-26 CN claimed
EP-4744682-A1 NOVEL CERIUM OXIDE NANOCOMPOSITE WITH ENHANCED BIOSTABILITY AND USE THEREOF Cenyx Biotech Inc. (KR) 2026-05-20 EP claimed
US-12458665-B2 Cerium oxide nanocomposite and use thereof CENYX BIOTECH INC. (KR) 2025-11-04 US claimed
CN-117820088-B Preparation method of m-ethylanisole 万华化学集团股份有限公司 2025-02-18 CN claimed
WO-2025014319-A1 NOVEL CERIUM OXIDE NANOCOMPOSITE WITH ENHANCED BIOSTABILITY AND USE THEREOF 주식회사 세닉스바이오테크 2025-01-16 WO claimed
CN-119040946-A Self-supporting cerium doped spinel nanosheet electrocatalyst and preparation method and application thereof 南京航空航天大学 2024-11-29 CN claimed
US-12077448-B2 Ceria nanoparticles and ceria nanoparticles preparation method Research & Business Foundation Sungkyunkwan University (KR) 2024-09-03 US claimed
CN-118315568-A Cerium-doped lithium-rich manganese-based positive electrode material coated by nano cerium oxide and preparation method thereof 中南大学 2024-07-09 CN claimed
CN-118022752-A Preparation method and application of sub-nano level monodisperse copper cerium oxide catalyst 北京工业大学 2024-05-14 CN claimed
CN-117987865-A Cerium doped ruthenium dioxide electrocatalyst and preparation method and application thereof 海南大学 2024-05-07 CN claimed
US-20130108526-A1 METHOD FOR MATERIALS RECOVERY FROM CATALYSTS COMPRISING IRON, CERIUM, MOLYBDENUM, AND POTASSIUM BASF SE (DE) 2013-05-02 US claimed
US-20120049181-A1 COMPOSITION FOR OXIDE THIN FILM, METHOD OF PREPARING THE COMPOSITION, METHOD OF FORMING THE OXIDE THIN FILM, AND ELECTRONIC DEVICE USING THE COMPOSITION INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) 2012-03-01 US claimed
US-7867463-B2 Process for producing cerium oxide nanocrystals INSTITUTE FOR BASIC SCIENCE (KR) 2011-01-11 US claimed
US-7811545-B2 Reacting a metal salt dissolved in water with an alkali metal salt of a carboxylic acid dissolved in a first hydrdocarbon solvent to form a metal carboxylate complex; heating the metal carboxylate complex dissolved in a second solvent of ethers to produce the highly crystalline nanoparticles SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) 2010-10-12 US claimed
US-7431758-B2 Cerium oxide particles and production method therefor NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2008-10-07 US claimed
EP-1945569-A1 PROCESS FOR PRODUCING CERIUM OXIDE NANOCRYSTALS Seoul National University Industry Foundation (KR) 2008-07-23 EP claimed
US-20070092423-A1 Process for producing cerium oxide nanocrystals INSTITUTE FOR BASIC SCIENCE (KR) 2007-04-26 US claimed
WO-2007043774-A1 PROCESS FOR PRODUCING CERIUM OXIDE NANOCRYSTALS SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) 2007-04-19 WO claimed
US-20060150526-A1 Cerium oxide particles and process for the production therefor NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2006-07-13 US claimed
US-20060032147-A1 Method of preparing slurry composition for chemical mechanical polishing SAMSUNG ELECTRONICS CO., LTD. (KR) 2006-02-16 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12458665-B2 Cerium oxide nanocomposite and use thereof CD59, CLN6, CERS2 CA4 306/4885CA1 300/4885FAHD1 4170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.